Behavioral Changes and [123I]IBZM Equilibrium SPECT Measurement of Amphetamine-Induced Dopamine Release in Rhesus Monkeys Exposed to Subchronic Amphetamine

[1]  P S Goldman-Rakic,et al.  Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.

[2]  J. Krystal,et al.  Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. , 1998, The American journal of psychiatry.

[3]  D. Wong,et al.  Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and Direct In Vitro Determinations , 1998, The Journal of Neuroscience.

[4]  G. Aghajanian,et al.  Molecular and cellular basis of addiction. , 1997, Science.

[5]  Sung-Cheng Huang,et al.  Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey , 1997, Brain Research.

[6]  E. Abercrombie,et al.  189 Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine , 1997, Schizophrenia Research.

[7]  S. J. Gatley,et al.  Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects , 1997, Nature.

[8]  A. Malhotra,et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P B Hoffer,et al.  Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.

[10]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Nestler,et al.  Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens , 1995, Brain Research.

[12]  E. Sybirska,et al.  Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates. , 1994, Nuclear medicine and biology.

[13]  P B Hoffer,et al.  In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography. , 1994, European journal of pharmacology.

[14]  Robert B. Innis,et al.  SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  P. Kalivas,et al.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity , 1991, Brain Research Reviews.

[16]  R. Kuczenski,et al.  Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  E. Nestler,et al.  A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function , 1991, Brain Research.

[18]  D. Segal,et al.  In vivo measures of monoamines during amphetamine-induced behaviors in rats , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  B L Holman,et al.  Brain perfusion SPECT using an annular single crystal camera: initial clinical experience. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  D. Segal,et al.  Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  H. Kung,et al.  Peracetic acid as a superior oxidant for preparation of [123I]IBZM: A potential dopamine D‐2 receptor imaging agent , 1989 .

[22]  R. Duman,et al.  Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. , 1988, The Journal of pharmacology and experimental therapeutics.

[23]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[24]  T. Crow,et al.  Behavioural and biochemical effects of chronic treatment with amphetamine in the vervet monkey , 1983, Neuropharmacology.

[25]  R. Ratan,et al.  The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. , 1982, Life sciences.

[26]  G. Ellison,et al.  Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. , 1978, Science.

[27]  A. Proakis,et al.  Comparative Penetration of Glycopyrrolate and Atropine across the Blood—Brain and Placental Barriers in Anesthetized Dogs , 1978, Anesthesiology.

[28]  P. Goldman-Rakic,et al.  Long-Lasting Psychotomimetic Consequences of Repeated Low-Dose Amphetamine Exposure in Rhesus Monkeys , 1999, Neuropsychopharmacology.

[29]  E. J. Nestler.  Cellular responses to chronic treatment with drugs of abuse. , 1993, Critical reviews in neurobiology.